key: cord-0322531-p5hjbxt2 authors: Ferrer-Torres, Daysha; Wu, Joshua H.; Zhang, Charles J.; Hammer, Max A.; Dame, Michael; Wu, Angeline; Holloway, Emily M.; Karpoff, Kateryna; McCarthy, Caroline L.; Bohm, Margaret S; Huang, Sha; Tsai, Yu-Hwai; Hogan, Simon P.; Turgeon, Danielle Kim; Lin, Jules; Higgins, Peter D.R.; Sexton, Jonathan; Spence, Jason R. title: In vitro models of the human esophagus reveal ancestrally diverse response to injury date: 2021-05-20 journal: bioRxiv DOI: 10.1101/2021.05.20.444920 sha: 1519ad1f6cf7c7f24cf9a17ee5c65bd1bd565105 doc_id: 322531 cord_uid: p5hjbxt2 European Americans (EA) are more susceptible to esophageal tissue damage and inflammation when exposed to gastric acid and bile acid reflux and have a higher incidence of esophageal adenocarcinoma when compared to African Americans (AA). Population studies have implicated specific genes for these differences; however, the underlying cause for these differences is not well understood. We describe a robust long-term culture system to grow primary human esophagus in vitro, use single cell RNA sequencing to compare primary human biopsies to their in vitro counterparts, identify known and new molecular markers of basal cell types, and demonstrate that in vivo cellular heterogeneity is maintained in vitro. We further developed an ancestrally diverse biobank and a high-content, image based, screening assay to interrogate bile-acid injury response. These results demonstrated that AA esophageal cells responded significantly differently than EA-derived cells, mirroring clinical findings, having important implications for addressing disparities in early drug development pipelines. drugs (Ortega and Meyers, 2014; Hunter, 2020) . Therefore, inclusion of individuals from diverse 53 demographics for drug development and clinical trials is important for ensuring efficacy across the 54 population. Although mandated by federal regulations and NIH policy, the inclusion of a diverse 55 population is still aspirational, and appropriately addressing racial disparities has faced criticism as 56 recently as the current COVID19 pandemic. Thus, failing to study racially/ancestrally and ethnically 57 diverse populations will leave critical gaps in our understanding of variation to drug responses, and the 58 effectiveness of new therapies. In the context of esophageal disease, genetic studies suggest racial 59 differences in the tissue response to cell and DNA damage-inducing agents leading to carcinogenesis 60 (Ferrer-Torres et al., 2019); however, the ability to study racial disparities in esophageal disease has 61 been hindered by the lack of diverse human models to study these mechanisms. In this study we aimed to first characterize the heterogenous cell types found in the 64 healthy/normal human esophagus in vivo, to establish a racially/ancestrally diverse esophageal 65 biobank of in vitro primary tissue lines, and to compare in vivo and in vitro-derived cultures using single-66 cell RNA sequencing (scRNA-seq). We developed a diverse biobank including tissue from individuals 67 self-identified as EA, AA, Asian, and Hispanic descent (n=55 cell lines) (Table 1 ). Using scRNA-seq, 68 we identified four molecularly distinct zones within the native in vivo esophageal epithelium and 69 validated new and known markers for each zone: basal (COL17A1 + , CAV1 + , CAV2 + ), suprabasal 70 (LY6D + ), mid-suprabasal (KRT4 + ), luminal zone (CRNN + ). We found that in vitro cultured cells could be 71 propagated for many generations, and while these cultures possessed an abundance of basal stem 72 cells, they also recapitulated the cellular diversity observed in the in vivo esophagus, including early 73 differentiating squamous cells. Secondly, we aimed to understand how these heterogenous cell types 74 respond to bile-acids. Multiple studies in animals have shown that bile acids, but not stomach acid 75 alone, contribute to the formation of columnar and glandular tissue, characteristic of Barrett's 76 Esophagus (Kauer et al., 1995; Quante et al., 2012; Straub et al., 2019) . Therefore, we developed an 77 image-based 384-well high content screening assay and image analysis pipeline yielding single-cell 78 phenotypic measurements. Machine learning was then used to interrogate cellular phenotypes and 79 showed that AA cells are less sensitive to damage by exposure of bile-acid, mimicking bile-acid reflux. 80 These results are consistent with clinical observations and suggest that in vitro human model systems 81 can capture genetic diversity leading to different biological response to injury 82 83 Results 84 85 Human adult esophagus epithelium contains molecularly-distinct zones defined by scRNAseq and 86 validated at the protein level 87 88 The esophagus its composed of a stratified squamous epithelium, underlying stromal tissue 89 (lamina propria) and smooth muscle (muscularis mucosae) (Rosekrans et al., 2015) . In order to 90 characterize the esophagus, we obtained normal/healthy squamous epithelial (normal squamous -91 "NS") adult human biopsies (approximately 3mm 2 ) (n=2 independent patients, with n=3-4 biopsies used 92 for dissociation), carried out enzymatic dissociation into single cells, which were captured using the 93 10X Chromium platform for subsequent sequencing. Louvain clustering analysis defined seven 94 transcriptionally distinct clusters ( Figure S1A -C, Table S1 ) , and defined classes of cells as Epithelial 95 (CDH1 + -Clusters 0,1,2,3) or stroma/lamina propria (VIM + -Clusters 4,5,6) which included immune 96 cells (Clusters 4/5) (Figure S1B-F). Contribution to each cluster was consistent across both biological 97 replicates ( Figure S1B ). The top 5 genes for each cluster were plotted ( Figure S1E ), and other enriched 98 genes for each cluster, which included known genes (Table S1 ) were used to identify cells associated 99 with different zones of the esophageal epithelium ( Figure S1E were further screened at the protein level using the Human Protein Atlas (HPA) (Uhlén et al., 2005, 106 2015), demonstrating that molecular identities correlated with different zones determined by protein 107 staining for different layers (basal, suprabasal, luminal) within the stratified epithelium ( Figure S1G ). 108 To further characterize the epithelium, CDH1-positive clusters were computationally extracted 109 and reclustered, revealing four predicted sub-clusters ( Figure 1A , Table S2 ). Individual biopsies 110 contributed to each cluster in similar proportions ( Figure 1B ). Unsupervised clustering was used to plot 111 the top 5 genes in an unbiased way ( Figure 1C , Table S2 ) and used to determine that epithelial clusters 112 correspond to basal cells (Cluster 2), proliferative (Cluster 1), suprabasal (Cluster 0), and a 113 differentiated/luminal zone cells (Cluster 3) ( Figure 1C , Figure S2A ). Of note, we observed that TP63, 114 a marker canonically used to identify basal cells, was broadly expressed in basal, proliferative and 115 transitional cell clusters ( Figure S2B ), a finding that was validated with protein staining, which showed 116 broad epithelial expression ( Figure S2C ). scRNA-seq data identified genes that were highly enriched 117 in the basal cell cluster (Cluster 2)( Figure 1C -D), which had specific localization to the basal cell layer 118 by immunofluescence, and included CAV1, CAV2, and COL17A1 ( Figure 1C -E, Figure S2 ). scRNA-119 seq identified LY6D as an enriched marker in the suprabasal/early transitional squamous and 120 proliferative cluster (Clusters 0, 1) ( Figure 1D , Figure S2 ). Supporting this, immunofluorescence shows 121 that LY6D protein is localized to the suprabasal zone just above the basal cell domain ( Figure 1E , 122 Figure S2C ), which is also where the majority of KI67+ proliferative cells are observed ( Figure 1E ). Within the suprabasal cluster (Cluster 0), we observed that KRT4 is expressed in a low-to-high gradient 124 ( Figure 1D ), and at the protein level, KRT4 marks the mid-point of the transitional zone, above the 125 LY6D+ epithelium ( Figure 1E , Figure S2C ). Finally, Cluster 3 represents a CRNN-high zone that marks 126 differentiated cells in the portion of the squamous epithelium near the lumen ( Figure 1C -E; Figure S2C ). 127 Altogether, we have mapped the epithelial zones of the esophagus at the mRNA and protein level, and 128 identified markers for each zone, with CAV1, CAV2 and COL17A1, uniquely marking the basal cells. Long term maintenance of patient-derived human esophageal basal-stem cells in vitro 131 132 In order to create a robust biorepository of diverse esophagus epithelial cell lines, we modified which eventually grew to confluence (Figure 2A -B). We observed that the irradiated 3T3-J2i cells do 138 not proliferate, while esophageal cells continue proliferating over time ( Figure 2C ). After three 139 passages, and 30-40 days in culture, we assessed cultures of these patient-derived in vitro esophagus 140 cells using scRNA-seq (n=3). We applied Louvain clustering to reveal five molecular clusters ( Figure 141 2D, Table S3 ), and plotted the proportion of total cells within each cluster ( Figure 2E ). All clusters were 142 enriched for the epithelial marker CDH1 expressed (average of biological replicates CDH1+ 96.6% vs 143 VIM+ 5.4%, (Figure S3E )) and protein staining revealed a high percentage of cells within the culture 144 were ECAD+ ( Figure 1F -G), a finding that was quantitated (% ECAD+ cells, n=7 independent lines, 145 Figure 2H top) demonstrating ~50-80% of cells were ECAD+, and that this did not change across 146 passage ( Figure 2H , bottom). The top 5 most highly enriched genes were plotted ( Figure S3A ) and 147 identified that Cluster 4 contains a proliferative signature, Clusters 1 and 2 expressed markers of basal-148 stem cells including CAV1, CAV2 and COL17A1 and known markers such as TP63, KRT15 and ITGB4 149 ( Figure 2I , Figure S3B -C) while Clusters 0 and 3 expressed markers of the suprabasal and luminal 150 zone ( Figure 2I ). these cells continue to co-express TP63 in vitro ( Figure 2J , Figure S3 D, F-G). Finally, we quantified 154 TP63 + /KI67 + cells culture, and observed that low density cultures grew as highly proliferative colonies 155 (n=3), while high density cultures formed a monolayer with significantly reduced proliferation ( Figure 156 3K), an observation that was validated in three independents cell lines. Together, these data suggest 157 that human esophagus epithelial cells are maintained in long-term culture, and that they retain many 158 molecular markers seen in vivo. Human-derived esophageal basal-stem cells molecularly resemble native tissue 161 162 To further interrogate how closely in vitro samples resemble in vivo esophageal tissue, we carried out 163 three complimentary but separate analyses using the data. First, we directly compared the single cell from in vivo tissue to each cluster versus the projected proportion from in vitro cells ( Figure 3H ). A high content bile-acid injury assay models racial disparities in EA and AA esophageal cell lines 196 197 High bile-acid content in gastric reflux has been associated with development and a higher incidence 198 of metaplastic progression (Stein et al., 1994; Nehra et al., 1999) . This suggests damage to the normal 199 squamous esophageal mucosa, which precedes the development of metaplasia, is an important target 200 for this bile-acid induced damage. The cell of origin of BE is still highly debated in the field (Que et al., 201 2019) but the role of bile acids is well established as a significant contributor to the development of BE 202 and consequently, EAC. Since the first tissue that is exposed to the reflux is the initially healthy 203 esophageal squamous epithelium, we wanted to test if AA-derived esophageal cells respond differently 204 to bile acid injury than EA-derived cells. To this end, we developed a bile acid injury assay compatible with high-content imaging based 207 screening, coupled with automated image analysis of cellular features using a Cell Painting (Bray et 208 al., 2016) style approach, followed by cell-level machine learning to characterize the perturbation of 209 cells to a mix of primary and secondary bile-acids known to be present in humans (bile-acid mix 210 (BAM)) (Nehra et al., 1999; Straub et al., 2019) see methods) ( Figure 4A , Figure S5 ). First, we tested 211 the individual and mixed bile-acids identified in human reflux (Straub et compared to individual bile acids ( Figure S5A-B) . Therefore, we proceeded to test the response of EA 216 and AA cells at 48hrs with increasing concentrations of BAM. After 48hrs of exposure to BAM, a visible 217 morphological change occurred in all patient-derived cell lines ( Figure 4B and Figure to obtain ~1,400 morphological features of each cell. To assess a cell line's susceptibility/response to bile acid damage, we developed a multivariate score 225 that predicts the amount of bile acid that each cell was exposed to base on its cellular response. This 226 was done using a random forest regression model classifying untreated and 3000 µM BAM treated 227 cells. ROC curve and confusion matrices determined high accuracy of this model ( Figure S6A -B). Measurements of compactness and form factor, two top contributing features to the model, 229 demonstrate that cells are elongated post BAM treatment and result in denser CellMask staining ( Figure 230 S6C). Predicted response as a percentage of 3000 µM BAM treated cells exhibited dose dependency 231 to actual treatment concentration, which was used to determine IC50, representing a concentration in 232 which the majority of cells turnover from healthy-like to damaged-like (see Methods). To interrogate the response of AA (n=3) or EA (n=3) cells to bile acid, we performed a blinded dose-235 response (0-3000µM) gradient and analyzed over a million cells per biological specimen. Samples were 236 unblinded only after all data analysis was completed for individual samples. After unblinding samples, 237 we observed that the average IC50 for EA derived esophageal cells is 130.4 µM, which is significantly 238 lower than the average IC50 observed in AA cell lines (1551 µM) ( Figure 4C -D)(P = 0.008). These 239 suggest that patient derived stem cells from EA are more susceptible to BAM induced injury than AA 240 stem cells. Even further, it suggests that this differential response mimics clinical observations that AA 241 esophagus are less susceptible to GERD related inflammation and BE when compared to EA. Here, scRNA-seq based characterization of the adult human esophagus in vivo and in vitro allowed us 251 to characterize the zonation of the stratified epithelium (basal, suprabasal, luminal) and to identify 252 several basal-cell specific markers of the stem cell zone, that had not been previously described (i.e. 253 CAV1, CAV2, COL17A1). Of note, we find that the transcription factor TP63, which is known for its role 254 in basal cell regulation in several tissues such as the skin, lungs and esophagus in mice is not restricted 255 to the basal zone in the human adult esophagus but is more broadly expressed throughout the basal 256 and suprabasal cell zones highlighting species-specific differences in gene/protein expression. Previous studies describing the growth of human esophagus in vitro have relied on the use of 259 canonical markers such as TP63 for validating cell types found in culture. Our single cell analysis 260 suggests that determining the heterogeneity within the in vitro environment by using TP63 or by using 261 methods that interrogate the ensemble of mRNA within a population of esophageal cells may be 262 difficult, given that there are many shared molecular and cellular markers within the basal and 263 suprabasal possessing significantly higher GSTT2 mRNA levels. However, the cellular tools to study the 273 mechanisms underlying these racial differences and to interrogate GSTT2 in both AA and EA tissue 274 models, were lacking. This is primarily due to a lack of stem-cell biobanks that represent the diversity 275 of the human population. To address this, we sought to establish a comprehensive and diverse stem-276 cell biobank of esophageal samples. To this end, we developed a biobank of esophageal cell lines from 277 across the diversity of the human population, and from a wide range of healthy and diseased states 278 (Table 1) . To further leverage this biobank, we developed and implemented a high-content bile-acid injury 281 response assay in vitro. Importantly, the in vitro findings that AA-derived stem cells are significantly 282 less sensitive to bile-acid induced injury than EA-derived stem cells reflect clinical observations that AA 283 have lower risk of BE and EAC relative to EA, even when risk factors such as acid reflux are identical 284 suggest that we can use patient-derived stem cells, and high-throughput models to better understand 289 the racial disparities in disease that have been reported for decades. Limitations of the study 292 293 During the course of this study, the global SARS-CoV-2 pandemic resulted in a research shut down 294 for several months, and a complete halt to research involving human patients for the majority of the 295 past year. This directly affected the ability for the study authors to collect new specimens over the 296 course of the past year in order to complete new experiments. An important caveat to our study is 297 that the racial identity given to a patient sample (and therefore each cells line), is based on the self-298 identification of race by individual tissue donors. Therefore, the specific genetic ancestry or ancestries 299 of the samples it is yet to be determined. Lastly, we note that while the biorepository reported herein 300 is diverse, representing individuals from multiple ancestries, it is still dominated by EA samples, and 301 as such, there is stillroom for improvement. Given the relatively high proportion of EA patients seen 302 by the University of Michigan, this may be most easily overcome by partnering with institutions or 303 research groups that have greater diversity in their patient populations. 304 305 Acknowledgements: JRS was supported by institutional funds and by a funding from the Chan 306 Zuckerberg Initiative Seed Network, and by the University of Michigan Center for Gastrointestinal 307 Research (UMCGR) (NIDDK 5P30DK034933). DFT was supported by the Center for Plasticity and 308 Organ Editing manuscript: all authors 320 321 322 Declaration of Interests: The authors declare no competing interests. 323 324 Sample collection 326 Histologically normal biopsies of the esophageal squamous epithelium with matched non-dysplastic 327 Barrett's esophagus (BE)(adjacent) were collected from consenting men and woman who underwent 328 upper endoscopy between 2017 and 2020 at the time of a scheduled BE screening at the University of 329 Michigan Health System. Samples were collected using protocols approved by the University of 330 Michigan institutional review board (IRB). Fresh samples were either used immediately for single cell 331 dissociation followed by scRNA-seq, or were processed for culture; otherwise, biopsies were 332 cryopsreserved and stored at -80 C until use, at which point they could be thawed and processed for 333 generating new culture lines. In order to cryopreserve biopsies, we mince tissue into fine pieces, and 334 freeze Imaging and image processing (Figure 1-2 Fluorescently-stained slides were imaged on a Nikon A-1 confocal microscope. Brightness and contrast 424 adjustments were carried out using ImageJ (National Institute of Health, USA) and adjustments were 425 made uniformly across images. Schematics and Diagrams 428 Schematic and diagrams in Figure 4A Sequencing data and processing FASTQ reads into gene expression matrices 449 All single-cell RNA sequencing was performed at the University of Michigan Advanced Genomics Core 450 with an Illumina Novaseq 6000. The 10x Genomics Cell Ranger pipeline was used to process raw 451 Illumina base calls (BCLs) into gene expression matrices. BCL files were demultiplexed to trim adaptor 452 sequences and unique molecular identifiers (UMIs) from reads. Each sample was then aligned to the 453 human reference genome (hg19) to create a filtered feature bar code matrix that contains only the 454 detectable genes for each sample. Quality control 457 To ensure quality of the data, all samples were filtered to remove cells expressing too few or too many 458 genes (Figure S1 Normalization and Scaling 462 Data matrix read counts per cell were log normalized, and highly variable genes were extracted. Using 463 Scanpy's simple linear regression functionality, the effects of total reads per cell and mitochondrial 464 transcript fraction were removed. The output was then scaled by a z-transformation. Following these 465 steps, a total of ( Figure Variable Gene Selection 471 Highly variable genes were selected by splitting genes into 20 equal-width bins based on log normalized 472 mean expression. Normalized variance-to-mean dispersion values were calculated for each bin. Genes 473 with log normalized mean expression levels between 0.125 and 3 and normalized dispersion values 474 above 0.5 were considered highly variable and extracted for downstream analysis. Batch Correction 477 We have noticed batch effects when clustering data due to technical artifacts such as timing of data 478 acquisition or differences in dissociation protocol. To mitigate these effects, we used the Python Cluster Annotation 500 Using canonically expressed gene markers, each cluster's general cell identity was annotated. Markers 501 utilized include epithelium (CDH1), mesenchyme (VIM), neuronal (POSTN, S100B, STMN2, ELAV4), 502 endothelial (ESAM, CDH5, CD34, KDR), and immune (CD53, VAMP8, CD48, ITGB2). Sub-clustering 505 After annotating clusters within the UMAP embedding, specific clusters of interest were identified for 506 further sub-clustering and analysis. The corresponding cells were extracted from the original filtered 507 but unnormalized data matrix to include ( Figure 1A/S2 -9039 cells, 3897 genes) . The extracted cell 508 matrix then underwent log normalization, variable gene extraction, linear regression, z transformation, 509 and dimension reduction to obtain a 2-dimensional UMAP embedding for visualization. 510 511 High-Content Imaging 512 ECAD quantifications ( Figure 2G-H 1.9 ) was used for cell object segmentation and measurements of ECAD intensity. 517 Threshold value for ECAD positivity was determined based on measured values for visually positive 518 cells in a subset of images. Cells with a measured ECAD value higher than the threshold was 519 determined to be positive. 520 521 Bile-Acid Treatment 522 ( Figure 4B -D, Figure S5 ) 523 Cells were cultured at an initial seeding density of 2,000 cells/well on PerkinElmer CellCarrier-384 Ultra 524 Microplates and grown for 48 hrs to 80% confluence. Cells were then treated with a 10-point, 1:3 serial 525 dilution, dose range of a bile-acid mixture from 0 to 3000 μM with 4 well-level replicated. After 48 hrs of 526 treatment, cells were fixed and stained with Hoechst 33342, Cell Mask Orange (nuclei and cell 527 boundary segmentation), and NFkB (cell stress). Confocal images were analyzed with Cell Profiler 528 3.1.9 to obtain nuclei and cell morphological features. Cells were then grouped by treatment and 529 analyzed using linear discriminant analysis in JMP Pro 14 which report a percent misclassification of 530 cells, i.e. the percentages of cells wrongly attributed to the wrong treatment group. Lower 531 misclassifications are representative of more distinctive morphological features, and therefore, higher 532 prediction accuracy by any treatment described a greater morphological perturbation from treatment. 533 Figure S5 ; To determine the percentage accuracy, each cell was classified as exhibiting an untreated 534 or high bile-acid treated phenotype based on linear discriminant analysis in JMP. Prediction accuracies 535 were determined based on the inverse of the reported misclassification rate. Higher accuracies 536 represent a more distinctive phenotype between untreated vs treated cell groups. CellProfiler was used for automated nuclei and cell segmentation followed by measurements of 539 morphological features (size and shape), intensity and distribution of stains amassing 1,400 unique 540 measured features per-cell. These measured features were normalized and filtered for low-variance 541 and high-correlation with Konstanz Information Miner (KNIME) (Berthold et al., 2006) . The markers localize COL17A1, CAV1, CAV2 (see Figure S2 ) at the basal zone, KI67 marks 562 proliferative cells at the basal-suprabasal zone, LY6D is negative in the basal layer and marks the first 563 suprabasal layer, KRT4 is an early differentiation marker, and CRNN stains the luminal/cell layer of 564 fully differentiated cell types. (Other markers validated in Figure S2 ). Scale bars represent 50 ìm 565 (Images are representative of n=3 biological replicates). 566 clustering and visualized via UMAP to predict five clusters. C1/C2 express basal cell markers (See 574 Figure 2I ), C0/3 express markers of early suprabasal cells, and C4 express proliferation markers. (Table 575 S3 confluent cell colonies are highly proliferative compared to high density, confluent monolayers (n=3; t-588 test; P < 0.001). All experiments were performed using at least n=3 biological replicates and t-test was 589 used to compare the mean of groups. Table S2 ) and in 593 vitro (Table S3) Tables 700 Table 1 Racial and Ethnic Disparities in the Prevalence of Barrett's Esophagus 708 Among Patients Who Undergo Upper Endoscopy Predicting the Future Burden of Esophageal Cancer by Histological Subtype: 711 International Trends in Incidence up to 2030 Dimensionality reduction for visualizing single-cell data using UMAP' KNIME: The konstanz information miner The Esophageal Epithelial Barrier in Health and Disease Fast unfolding of communities in large networks Article Human gastrointestinal epithelia of the esophagus , stomach , and 722 duodenum resolved at single-cell resolution ll ll Human gastrointestinal epithelia of the esophagus , 723 stomach , and duodenum resolved at single-cell resolution Cell Painting, a high-content image-based assay for morphological profiling 726 using multiplexed fluorescent dyes Cellular heterogeneity in the mouse esophagus 729 implicates the presence of a nonquiescent epithelial stem cell population Associations between di V erent forms of gastro-732 oesophageal reflux disease Gastroesophageal reflux among different racial groups in the United 734 States Update on the epidemiology of gastro-oesophageal reflux disease: a 736 systematic review Constitutively Higher Level of GSTT2 in Esophageal Tissues From 738 Journal -2010 -New engla nd journal Aspirin prevents NF-κB activation and CDX2 expression stimulated by acid and 743 bile salts in oesophageal squamous cells of patients with Barrett's oesophagus', Gut Expansion of airway basal epithelial cells from primary human non-small 746 cell lung cancer tumors The bile acid deoxycholic acid (DCA) at neutral pH activates NF-748 kappaB and induces IL-8 expression in oesophageal cells in vitro Mixed reflux of gastric and duodenal juices is more harmful to the 751 esophagus than gastric juice alone: The need for surgical therapy re-emphasized Integrated genomic characterization of oesophageal carcinoma', Nature The influence of genetics on cystic fibrosis phenotypes', Cold 756 Spring Harbor Perspectives in Medicine Available at: 758 papers3://publication/uuid/22668F87-86F6-4048-93C6-52275B30A283 NF-κB signaling in inflammation Conditional reprogramming and long-term expansion of normal and tumor cells 762 from human biospecimens CellProfiler 3.0: Next-generation image processing for biology Dual SMAD Signaling Inhibition Enables Long-Term Expansion of Diverse 766 Toxic bile acids in gastro-oesophageal reflux disease: Influence of gastric 769 acidity Pharmacogenetics: Implications of race and ethnicity on 771 defining genetic profiles for personalized medicine Redox Biology The antioxidant response in Barrett ' s tumorigenesis : A 774 double-edged sword In Barrett's esophagus patients and Barrett's cell lines, ursodeoxycholic acid 776 increases antioxidant expression and prevents DNA damage by bile acids Geographical Distribution and Racial Disparity in Esophageal 780 Cancer', The Annals of thoracic surgery BBKNN: Fast batch alignment of single cell transcriptomes Bile acid and inflammation activate gastric cardia stem cells in a mouse 785 model of barrett-like metaplasia', Cancer Cell Pathogenesis and Cells of Origin of Barrett's Esophagus Incidence of esophageal adenocarcinoma in patients with Barrett's 790 esophagus and high-grade dysplasia: a meta-analysis Esophageal development and epithelial homeostasis From Barrett metaplasia to esophageal adenocarcinoma : the molecular 796 background Histology and Histopathology Racial and Geographic Issues in Gastroesophageal Reflux Disease Racial differences in the frequency of symptoms and complications of 801 gastro-oesophageal reflux disease Alkaline Gastroesophageal Reflm : Assessment by Ambulatory Esophageal 804 Aspiration and pH Monitoring Glyco-conjugated bile acids drive the initial metaplastic gland formation from 806 multilayered glands through crypt-fission in a murine model Esophageal cancer: An updated surveillance epidemiology and end results 809 database analysis Sex and Racial Disparity in Incidence of Esophageal 811 Adenocarcinoma: Observations and Explanations A Human Protein Atlas for Normal and Cancer Tissues Based on Antibody 814 Tissue-based map of the human proteome A human protein atlas for normal and cancer tissues based on antibody 819 proteomics Tissue-based map of the human proteome SCANPY: large-scale single-cell gene expression 824 data analysis Racial and Ethnic Disparities in the Incidence of Esophageal Cancer in the 827 Unived States Mutational spectrum of Barrett's stem cells suggests paths to initiation of 829 a precancerous lesion', Nature Communications